뒤로
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.(2315.HK) 가격
2315.HK 주가 차트
BIOCYTOGEN-B (2315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$40.88
-5.54%
$-2.39
정규장: Jan 19, 13:33:51 HKT
주요 통계
이전 종가
$43.28
시가
$43.28
일일 범위
$40.24 - $43.28
52주 범위
$7.25 - $48.26
거래량
859.0K
평균 거래량
1.0M
EPS(TTM)
0.37
배당수익률
--
시가총액
$4.3B
BIOCYTOGEN-B란 무엇인가요?
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.